Bone and Soft Tissue Pathology E-Book e-bog
1313,81 DKK
(inkl. moms 1642,26 DKK)
Now fully revised to include recent advances in the field, the second edition of Bone and Soft Tissue Pathology, a volume in the Foundations in Diagnostic Pathology series, is an essential foundation text for residents and pathologists. The popular template format makes it easy to use, and new information throughout brings you up to date with what's new in the field, including advances in molec...
E-bog
1313,81 DKK
Forlag
Elsevier
Udgivet
11 februar 2022
Længde
544 sider
Genrer
Pathology
Sprog
English
Format
pdf
Beskyttelse
LCP
ISBN
9780323758727
Now fully revised to include recent advances in the field, the second edition of Bone and Soft Tissue Pathology, a volume in the Foundations in Diagnostic Pathology series, is an essential foundation text for residents and pathologists. The popular template format makes it easy to use, and new information throughout brings you up to date with what's new in the field, including advances in molecular diagnostic testing and new diagnostic biomarkers. Practical and affordable, this resource is ideal for study and review as well as everyday clinical practice.Key features of this practical text include: A consistent, user-friendly format that explores each entity's clinical features, pathologic features (gross and microscopic), ancillary studies, differential diagnoses, and prognostic and therapeutic considerations. A focus on specific features of selected neoplastic and non-neoplastic entities, including broad and in-depth differential diagnoses. Review of normal histology before examining abnormal findings, enabling you to conveniently compare their characteristics in one place at one time. Clinical information on treatment and prognosis, enabling you to better understand the clinical implications of the diagnosis. Nearly 1,000 full-color, high-quality illustrations with extensive figure legends, as well as abundant boxes and tables throughout. What's NEW in this edition: Advances in molecular diagnostic testing and its capabilities and limitations, including targeted/personalized medicine. New diagnostic biomarkers and their utility in differential diagnosis, newly described variants, and new histologic entities. The latest TNM staging and WHO classification systems. New co-editor Dr. Gunnlaugur Petur Nielsen of Harvard Medical School joins Dr. Andrew L. Folpe and expert, internationally recognized pathologists who keep you up to date with the latest information in the field.